Skip to main content
. Author manuscript; available in PMC: 2013 Jun 24.
Published in final edited form as: Int J Gynecol Cancer. 2011 Aug;21(6):1084–1090. doi: 10.1097/IGC.0b013e3182187324

FIGURE 3.

FIGURE 3

Representative migration assay on USPC-ARK 2. Increasing concentrations of intetumumab inhibit the migration of USPC-ARK-2 cells through an 8.0-μm pore polycarbonate membrane, mediated by a chemoattractant stimulus. Extent of cell migration in the presence of various concentrations of antibody is shown as absorbance of the solution after lysis of stained migrated cells. Data shown are mean (±SEM) of at least 3 different experiments. *P ≤ 0.03 versus the condition in the absence of any antibody.